The private GP EHR market in the UK is predicted to grow due to a rise in demand for private healthcare services, linked to a decline in NHS general practitioners, along with the development of medical technology integrating EHRs. However, the risk of cyber attacks and other technical issues could limit the adoption of EHR systems by private GPs.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused
